AHPRA Cooling Off Period Aesthetic Consultation

For years, the aesthetic treatments industry in Australia operated under regulatory frameworks that were sufficient for medical practice in general but not specifically calibrated for the patient experience around appearance based care. AHPRA’s September 2025 guidelines closed several of those gaps. The mandatory seven day cooling off period for patients under 18 is one of the more visible reforms, but it is part of a broader change in expectation around how consent is obtained, when payment can be taken, and what advertising is permitted.

This article explains what the cooling off period actually requires, the clinical reasoning behind it, and how the underlying principle, that decisions about your appearance should be made in a different emotional state from the one a consultation can produce, applies more broadly than the regulation strictly mandates. Core Aesthetics is run by Corey Anderson, Registered Nurse (AHPRA NMW0001047575), registered since 1996.

What the September 2025 Reform Actually Says

The reform was published by AHPRA and the National Boards under the heading Guidelines for registered health practitioners who perform nonsurgical cosmetic procedures, and came into effect on 2 September 2025. For patients under the age of eighteen, three measures apply together: a mandatory seven day cooling off period must elapse between the consultation at which informed consent is provided and the day on which the procedure is carried out; payment cannot be accepted before the cooling off period has ended, other than for the cost of the initial consultation itself; and advertising aimed at people under eighteen is prohibited.

For patients aged eighteen and over, the seven day cooling off period is not a regulatory mandate. The new guidelines do, however, reinforce the broader expectation that informed consent must be obtained meaningfully, that advertising must not unduly influence decision making, and that practitioners must consider whether a second consultation is appropriate before proceeding with treatment. The intent is to lift the standard of care across the whole of the industry, not only for under-18s.

Why a Cooling Off Period Was Specifically Introduced for Under-18s

The clinical reasoning is twofold. The adolescent and early adult brain is still completing maturation of the prefrontal cortex, the region most responsible for weighing long term consequences against immediate emotional reward. Decisions made in a clinical environment, particularly ones involving appearance, can be disproportionately influenced by the immediate setting. A mandatory pause separates the consultation environment from the decision environment.

The second reason is the structure of the cosmetic industry as it had developed by the early 2020s. Same day treatment had become normalised, particularly in higher volume clinics, and the financial structure of those clinics often made consent and procedure feel like a continuous transaction rather than two distinct clinical events. The cooling off period for under-18s makes that conflation impossible by force of regulation, and it sends a clear signal about what good practice should look like for adults too.

What the Cooling Off Period Looks Like in Practice

For a patient under 18, the practical sequence is as follows. The first appointment is a consultation. A full medical and treatment history is taken, the assessment is performed, the realistic indications and limitations of any proposed treatment are explained in language the patient and any accompanying parent or guardian can confirm they understand, and consent documentation is provided. No procedure is performed at this appointment, and no payment beyond the initial consultation fee is accepted.

Seven days then pass. During this period, the patient is free to ask further questions, to consult others, and to change their mind without consequence. If, after seven days, the patient confirms that they wish to proceed, a second appointment is scheduled. Treatment is performed at that second appointment. The full sequence is documented in the clinical record.

Why Core Aesthetics Does Not Treat at First Appointment for Any Patient

The clinical case for separating consultation from treatment is not unique to under-18s. Adults, too, benefit from time between hearing the assessment and acting on it, particularly when first time treatment is being considered, when a long term plan is being discussed, or when the consultation has uncovered a concern that the patient had not consciously articulated before walking in.

At Core Aesthetics, no procedure is performed at a first appointment for any patient, regardless of age. This standard predates the AHPRA reform and is not driven by it. It exists because separating the two appointments produces better informed patients, more considered treatment plans, and a quieter, more honest decision process. It is also a deliberate counterweight to a market in which same day treatment has been over normalised.

Advertising Restrictions That Apply to All Practices

Alongside the cooling off period, the September 2025 reform tightened advertising restrictions across the industry. Advertising aimed at under-18s is now explicitly prohibited. For all audiences, advertising must not exaggerate the benefits of a procedure, must not claim specific outcomes, must not use endorsements about clinical services, must not use before and after imagery in misleading ways, and must not include inducements such as time limited price reductions that could pressure a decision.

These rules sit on top of the existing Therapeutic Goods Advertising Code, which governs how prescription only products such as aesthetic treatments can be advertised. In practice, the combined effect is that any advertising that names a specific aesthetic treatment product, claims a assured result, or uses time pressure to influence a decision is non compliant. The standard of compliant advertising in this category is significantly higher than for most consumer industries.

Informed Consent Under the New Standard

The reform also clarified what counts as informed consent in aesthetic treatment practice. Consent must be obtained in writing, after a clinical consultation, in language the patient demonstrably understands. The information provided must include the realistic outcomes of the procedure, the recognised risks including those that are uncommon but serious, the alternatives, the cost structure, the expected longevity of any result, and the practitioner’s qualifications. The patient must have the opportunity to ask questions, and the consent process must be documented in the clinical record.

For prescription aesthetic treatments, the prescription itself must be authorised by an appropriately qualified practitioner, with the prescriber having either personally seen the patient or made the prescribing decision in line with current National Boards guidance. The September 2025 framework is more specific about this than earlier guidance, and it has narrowed the gap between what was previously considered acceptable and what is now required.

What Patients Should Expect From a Compliant Consultation

A compliant consultation, whether at Core Aesthetics or anywhere else operating to AHPRA’s September 2025 standard, will include a documented medical history, an in person clinical examination, a written treatment plan or a clear written record that no treatment was recommended, written consent documentation that the patient is given time to read, an explanation of risks specific to the proposed treatment area, an explanation of alternative options including no treatment, and a discussion of any cooling off period that applies.

If a clinic appears willing to bypass any of these elements, that is a sign that the practice is operating below the current standard of care. A consultation that begins with a price quote, a consultation that includes payment for the treatment itself rather than only the consultation fee, or a consultation followed immediately by a procedure without any opportunity to consider the plan are all behaviours that the September 2025 reforms were designed to discourage.

Reading the Reform Honestly

The September 2025 guidelines do not change the underlying biology of aesthetic treatment, do not alter what is or is not appropriate for an individual face, and do not introduce a new style of clinical practice. What they do is codify a higher standard of patient experience, particularly around vulnerable groups, and align the regulatory minimum more closely with what good clinical practice has always looked like.

For patients, the practical takeaway is that the consultation is now formally distinct from the procedure, that under-18s have an enforced pause between the two, and that any advertising or pricing structure that pressures a same day decision is incompatible with the current framework. For practitioners who already treat consultation as a first appointment in its own right, the reform formalises an existing standard rather than imposing a new one.

If You Are Considering Treatment in Melbourne’s South-East

Core Aesthetics is at 12A Atherton Road, Oakleigh VIC 3166. The clinic is reachable from Carnegie, Murrumbeena, Hughesdale, Chadstone, Huntingdale, Clayton, Mount Waverley, Glen Waverley, Bentleigh, McKinnon, Cheltenham, and Malvern East within fifteen to twenty minutes outside peak. Oakleigh station, on the Cranbourne and Pakenham lines, is a short walk from the clinic.

The first appointment is always a consultation. Treatment is scheduled separately, after the assessment has been considered and the plan has been written. To enquire about a consultation, please contact the clinic.

Where to Read the Source Documents

The September 2025 cosmetic procedures guidelines and supporting documents are published on the AHPRA website. The cosmetic procedure guidelines page is the primary reference. The Therapeutic Goods Administration also maintains information about how aesthetic treatment products are regulated as therapeutic goods, including how they may and may not be advertised. Reading both is the most reliable way to understand the framework in which any compliant Australian aesthetic treatment practice operates.

Where the Reform Sits in the Broader Australian Framework

The September 2025 guidelines do not exist in isolation. They sit alongside the Therapeutic Goods Act and Advertising Code, which govern how prescription aesthetic treatment products may be advertised; the Health Practitioner Regulation National Law, which governs the registration, conduct, and discipline of health practitioners; and individual State and Territory legislation governing the prescribing, supply, storage, and administration of Schedule 4 medicines. Understanding any one of these in isolation gives a partial picture; the working framework is the combination of all of them.

For practitioners, the practical effect is that compliance is not a single document to read once. It is a small group of documents that overlap, with the strictest provision in any area setting the operative rule. For patients, the practical effect is more straightforward: a practice that can describe how it complies with each of these frameworks, and that can produce documentation supporting that description, is operating to a recognisable standard. A practice that cannot, regardless of how well its marketing reads, is operating below the standard the combined framework defines.

What the September 2025 Reform Did Not Change

It is worth being clear about the scope of the reform. The September 2025 guidelines did not change the underlying biology of aesthetic treatment products, did not change which active ingredients are approved by the Therapeutic Goods Administration, and did not change the clinical indications for which those products are appropriate. The mechanism of action of wrinkle injection is unchanged, the contraindications are unchanged, and the recovery course after treatment is unchanged.

What did change is the surrounding architecture: how consent is obtained, when payment can be accepted, what advertising is permitted, what additional safeguards apply to under-18s, and what counts as a defensible record of the consultation. The clinical decision itself, whether a particular face is appropriate for a particular treatment on a particular day, sits exactly where it did before, in the relationship between practitioner and patient, informed by assessment and history.

This distinction is sometimes lost in coverage of the reform, which has tended to focus on the cooling off period as a single dramatic change. The more accurate framing is that the reform tightened a series of process expectations that good practice was already meeting and that some practices were not. For patients seeking treatment from a practice that already operates at the higher end of compliance, the reform is largely invisible. For patients evaluating whether a practice is worth visiting, the reform offers a useful set of markers to look for: written consent, separated consultation and procedure, no time limited pressure, and a practitioner happy to defer or decline if the assessment supports it.

How to Recognise a Practice Working to the Standard

Several practical signals suggest a clinic is operating to or above the September 2025 standard. The consultation appointment is offered as a separate booking with a stated fee, rather than bundled into a procedure that has already been priced. The clinic publishes the qualifications of its treating practitioner clearly, including registration number, primary qualification, and the years of practice in injectable specifically. The booking system does not pressure a same day procedure decision, and the clinic does not maintain a steady drumbeat of time limited promotional pricing on prescription products.

Conversely, several practical signals suggest a clinic is operating below the standard. Same day treatment is presented as the default rather than the exception. Pricing materials reference brand names of prescription aesthetic treatment products explicitly. Promotional pricing is structured around urgency, with countdown timers, weekend specials, or membership tiers that reward frequency rather than clinical appropriateness. Reviews on the clinic’s own marketing materials describe outcomes of regulated procedures in patient endorsements, which is non compliant under the broader Therapeutic Goods Advertising Code.

None of these signals are absolute. A clinic that fails one of them is not necessarily unsafe; a clinic that meets all of them is not automatically the right clinic for any individual patient. They are, however, useful starting points for evaluating whether the practice is operating in the same regulatory frame the September 2025 guidelines define, or in a frame that has not yet caught up.